Computational discovery of <i>PGD</i>, <i>MAPK14</i>, and <i>KRAS</i> as diagnostic biomarkers for neonatal sepsis through integrated machine learning, immune infiltration analysis, and molecular docking. [PDF]
Front ImmunolLuo L, Chen J, Du W, Hu J.
europepmc +1 more source
Dasatinib: A Novel Etiology of Reversible Cerebellar Ataxia. [PDF]
Ann Indian Acad NeurolMustafa F +3 more
europepmc +1 more source
Construction of a Prognostic Model and Subgroup Characteristics Related to Hypoxia-Immune Evasion in T Cells of Hepatocellular Carcinoma Based on Single-Cell and Bulk RNA Analysis. [PDF]
J Hepatocell CarcinomaMa X, Ying L, Xiang X.
europepmc +1 more source
Targeting SRC/STAT3 Signaling Impairs Cancer Stem Cell Activity by Downregulation of Hexokinase-2 in Radioresistant Triple-Negative Breast Cancer Cells. [PDF]
Oncol ResHuang YH +7 more
europepmc +1 more source
Chemotherapy-driven expression of WNT ligands in bone marrow stromal cells contributes to chemoresistance in acute lymphoblastic leukaemia. [PDF]
Br J HaematolKalampalika F +4 more
europepmc +1 more source
Adverse Respiratory Reactions to Tyrosine Kinase Inhibitors: A Disproportionality Analysis of Spontaneous Reports from European Countries. [PDF]
Life (Basel)Ammendolia I +9 more
europepmc +1 more source
Screening of kinase inhibitors in the triple negative KRAS G13D-mutated MDA-MB-231 breast cancer cell line. [PDF]
Sci RepStickler S +7 more
europepmc +1 more source
Real-World Outcomes With Low-Dose Dasatinib (50 mg) in Imatinib-Resistant Chronic Myeloid Leukemia in Chronic Phase: A Retrospective Analysis of Efficacy and Safety. [PDF]
Cancer Rep (Hoboken)Gangadaran N +9 more
europepmc +1 more source
Safety profiles of dasatinib in pediatric patients: a real-world pharmacovigilance assessment based on the FAERS database. [PDF]
Jpn J Clin OncolYang Y, Ma W, Fu H, Zhou Y, Lin Y.
europepmc +1 more source